Ischemic stroke. Cerebral infarction
Conditions
Interventions
Intervention 1: Intervention group: edaravone drug, 30 mg of the drug dissolved in 100 mg of normal saline for 60 minutes, will receive twice a day by injection for 10 days. Intervention 2: Control gr
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Participants with ischemic stroke based on clinical symptoms and CT scan Participants with ischemic stroke and NIHSS score of 16
Exclusion criteria
Exclusion criteria: Unwillingness to participate Significant cognitive and neurological impairments Presence of hemorrhagic stroke
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ischemic Severity. Timepoint: First and 10 days after intervention. Method of measurement: CT scan.;Radiological improvement rate. Timepoint: First and 10 days after intervention. Method of measurement: CT scan.;Rate of clinical improvement. Timepoint: First and 10 days after intervention. Method of measurement: NIHSS Scoring.;The level of consciousness of the patient. Timepoint: First and 10 days after intervention. Method of measurement: GCS scoring system. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeid Razmeh
Yasouj University of Medical Sciences
Outcome results
None listed